Alexion Pharmaceuticals, Inc. · 1 month ago
Programme Director – PPM Data Transformation
Alexion Pharmaceuticals, Inc. is embarking on a bold PPM data transformation journey to build a high-quality, accessible, and future-ready data platform. The Programme Director, PPM Data Transformation, will provide strategic leadership for this critical programme, overseeing end-to-end delivery and establishing effective governance to achieve the organization's ambitious vision.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Lead the scoping, planning, and execution of the PPM Data Transformation. Track benefits and value realization. Own the roadmap, milestones, risks, dependencies, and integrated plans
Establish best practice programme governance, status reporting cadences, risk and issue management, and programme documentation standards. Ensure decisions, protocols, and controls are clear and traceable
Partner across GPPM, R&D, Finance, IT and external vendors; align with executive sponsors and governance forums to enable adoption, unblock decisions and achieve the goal of an integrated platform at the enterprise level
Lead change management planning and execution. Communicate with key user groups and develop role-based training strategies. Coach SMEs and leaders to embed a data-driven culture
Define and track KPIs/OKRs. Manage budget and resources. Provide transparent progress, risk, and mitigation reporting to senior leadership. Ensure incremental value delivery through phased releases
Bring in external best practices, emerging technologies and partner capabilities to simplify processes and improve decision and delivery velocity
Surface and understand dependencies across the PPM Platform, including enterprise-driven initiatives that shape PPM data (e.g. ABACUS & AXIAL) and the evolving strategic roadmap for key GPPM capabilities (Project Management, Capacity Management, Governance & P2P, Portfolio Analytics)
Qualification
Required
Extensive track record (10+ years) leading complex, cross-functional transformation programmes in data strategy, portfolio/project management, or digital change environments
Proven success driving cross-functional teams in the implementation of integrated data platforms, governance frameworks and digital workflow solutions
Executive influence and communication skills; able to cut through complexity and target clear messages to senior leaders and governance forums
Evidence of successfully delivering incremental programme value, building agile teams, and embedding organizational culture change
Demonstrated uplift of PMO maturity and continuous improvement, with strong risk management and delivery excellence
Data and analytics literacy, including modern data management methodologies, AI/ML, insight generation and technology-enabled change
Bachelor's / Master's in business, technology or related discipline
Strong network to external thought leadership in PMO, data and digital transformation
Preferred
Background / experience in life sciences preferred
Understanding of the pharmaceutical business (including R&D, Operations, Commercial, Finance, etc)
Vendor selection and management in partnership with Procurement/IT
PMP/PgMP or equivalent
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
H1B Sponsorship
Alexion Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (49)
2024 (57)
2023 (51)
2022 (29)
2021 (27)
2020 (17)
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase